Evidence map›Paper›PMID 9671496›Full record

ArticleMolecular and cellular biology1998

Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl-deficient mice.

M A Murphy, R G Schnall, D J Venter, L Barnett, I Bertoncello, C B Thien, W Y Langdon, D D Bowtell

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 145 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
145citing papers in PubMed, 1 pooled it
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

145 citing papers in PubMed, 1 synthesis or guideline pooled it, 363 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Srsf2Leukemia · 2022
    Article
  7. Protein ubiquitination in T cell development.Frontiers in immunology · 2022
    Review
  8. T cell receptor (TCR) signaling in health and disease.Signal transduction and targeted therapy · 2021
    Review
  9. Article
  10. Review
  11. Perfect adaptation of CD8Science signaling · 2021
    Article
  12. C-Cbl regulates c-MPL receptor trafficking and its internalization.Journal of cellular and molecular medicine · 2020
    Article
  13. Article
  14. UBASH3A Regulates the Synthesis and Dynamics of TCR-CD3 Complexes.Journal of immunology (Baltimore, Md. : 1950) · 2019
    Article
  15. Review
  16. Review
  17. Article
  18. Expression and Comparison of Cbl-b in Lung Squamous Cell Carcinoma and Adenocarcinoma.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
  19. CD5, an Undercover Regulator of TCR Signaling.Frontiers in immunology · 2018
    Review
  20. Review

85 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

M A MurphyTrescowthick Research Laboratories, Peter MacCallum Cancer Institute, Melbourne 3000, Parkville 3050, Victoria, Australia.
R G Schnall
D J Venter
L Barnett
I Bertoncello
C B Thien
W Y Langdon
D D Bowtell
Peter MacCallum Cancer Centre · AUUniversity of Western Australia · AUThe Royal Melbourne Hospital · AU

Funding

Wellcome Trust
6 · The paper itself

Abstract

The c-Cbl protein is tyrosine phosphorylated and forms complexes with a wide range of signalling partners in response to various growth factors. How c-Cbl interacts with proteins, such as Grb2, phosphatidylinositol 3-kinase, and phosphorylated receptors, is well understood, but its role in these complexes is unclear. Recently, the Caenorhabditis elegans Cbl homolog, Sli-1, was shown to act as a negative regulator of epidermal growth factor receptor signalling. This finding forced a reassessment of the role of Cbl proteins and highlighted the desirability of testing genetically whether c-Cbl acts as a negative regulator of mammalian signalling. Here we investigate the role of c-Cbl in development and homeostasis in mice by targeted disruption of the c-Cbl locus. c-Cbl-deficient mice were viable, fertile, and outwardly normal in appearance. Bone development and remodelling also appeared normal in c-Cbl mutants, despite a previously reported requirement for c-Cbl in osteoclast function. However, consistent with a high level of expression of c-Cbl in the hemopoietic compartment, c-Cbl-deficient mice displayed marked changes in their hemopoietic profiles, including altered T-cell receptor expression, lymphoid hyperplasia, and primary splenic extramedullary hemopoiesis. The mammary fat pads of mutant female mice also showed increased ductal density and branching compared to those of their wild-type littermates, indicating an unanticipated role for c-Cbl in regulating mammary growth. Collectively, the hyperplastic histological changes seen in c-Cbl mutant mice are indicative of a normal role for c-Cbl in negatively regulating signalling events that control cell growth. Consistent with this view, we observed greatly increased intracellular protein tyrosine phosphorylation in thymocytes following CD3epsilon cross-linking. In particular, phosphorylation of ZAP-70 kinase in thymocytes was uncoupled from a requirement for CD4-mediated Lck activation. This study provides the first biochemical characterization of any organism that is deficient in a member of this unique protein family. Our findings demonstrate critical roles for c-Cbl in hemopoiesis and in controlling cellular proliferation and signalling by the Syk/ZAP-70 family of protein kinases.

Indexed as

Signal TransductionUbiquitin-Protein LigasesAnimalsBone DevelopmentBone RemodelingCD3 ComplexCD4-CD8 RatioCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesFemaleGene DeletionGene TargetingHyperplasiaMaleMammary Glands, AnimalMiceCbl protein, mouseCD3 ComplexProtein-Tyrosine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-cblUbiquitin-Protein LigasesZap70 protein, mouseZAP-70 Protein-Tyrosine Kinase

Identifiers

PMID9671496
PMCPMC109072
OpenAlexW2116023341

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.